Treatment for Evans Syndrome

Definition and Diagnosis

The American College of Physicians recommends a diagnostic workup that includes complete blood count with differential, peripheral smear, and reticulocyte count for patients with suspected Evans syndrome 1
The diagnostic workup should also include a direct antiglobulin test (DAT) to confirm the autoimmune hemolytic anemia component 1
Testing for underlying conditions, including infections such as HIV, hepatitis C virus, hepatitis B virus, CMV, and Helicobacter pylori, is recommended 1, 2
Evaluation for lymphoproliferative disorders and autoimmune conditions, such as systemic lupus erythematosus and antiphospholipid syndrome, is also necessary 1
Bone marrow evaluation may be necessary if abnormalities in blood tests require further investigation 3

The American Society of Hematology recommends first-line treatment with corticosteroids, such as prednisone 1-2 mg/kg/day orally, until platelet count increases to 30-50 × 10^9/L 1
The treatment should continue for 2-4 weeks, then taper over 4-6 weeks to the lowest effective dose 3
Intravenous Immunoglobulin (IVIg) can be added to corticosteroids when a more rapid increase in platelet count is required, with an initial dose of 1 g/kg as a one-time dose 1, 3
Thrombopoietin receptor agonists, such as eltrombopag and romiplostim, are recommended for chronic immune thrombocytopenia component, with response rates of 70-81% for eltrombopag and 79-88% for romiplostim 4

For patients with secondary Evans syndrome associated with HIV, treatment with antiretroviral therapy is recommended before other treatments, unless significant bleeding is present 2, 5
For patients with secondary Evans syndrome associated with HCV, consideration of antiviral therapy is recommended, with close monitoring of platelet counts due to potential worsening with interferon-based regimens 2, 5
For patients with secondary Evans syndrome associated with H. pylori, administration of eradication therapy is recommended 5

The American Society of Hematology recommends evaluating response based on platelet count improvement, with a goal of >30 × 10^9/L and at least 2-fold increase from baseline 1
Monitoring for resolution of hemolysis, including improved hemoglobin, decreased reticulocyte count, and normalized bilirubin, is also necessary 1

The American Society of Hematology notes that when immune thrombocytopenic purpura (ITP) occurs with additional autoimmune cytopenias (Evans syndrome), the clinical course differs significantly from primary ITP, requiring more aggressive treatment 6

Evans syndrome requires more aggressive treatment than isolated autoimmune cytopenias due to higher relapse rates, increased risk of thrombotic complications, greater risk of infectious complications, and potentially fatal outcomes, as stated by the American Society of Hematology 6